dpp-4 inhibitors and glp-1 agonists Clinical Use of The Impact of Dipeptidyl-peptidase 4
Description
Medicare recipients who meet the eligibility requirements will have to pay a $50 monthly copay to access the GLP-1 drugs
Therefore, this compound seems to be not solely a new antidiabetic medication
Work closely with your healthcare provider to evaluate your options, monitor your response, and make adjustments as needed
15,19,22,23,31,32,38,39,41,43 TAKE-HOME MESSAGE Lifestyle modification remains the foundation of MASH management, 9 with weight loss of at least 10% associated with fibrosis regression in most patients
Subgroup analysis based on the dosage of drugs could not be done for the same reason mentioned for the follow-up period
Consequently, GLP-1RAs are recommended as a first-line injectable therapy for patients requiring pharmacological intervention to achieve glycemic control [7]
